E-DRUG: Pharmaceutical Pricing & Reimbursement Conference, Vienna, 23-24 Oct 2019 - Call for abstracts & registration
-------------------------------------------------------------------------------------------------
Dear E-Druggers,
The WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies organises the 4th international PPRI Conference, entitled 'Medicines access challenge - The value of pricing and reimbursement policies', held in Vienna on 23-24 October 2019.
Access to medicines still remains a challenge in the twenty-first century, and policy-makers aim to balance the partially conflicting objectives of providing access to medicines, containing costs and rewarding innovation in pharmaceutical development. In recent years, some very expensive medicines have entered the markets, putting the long-term financial sustainability of health systems at risk. In this context, the design of the pricing and reimbursement policies is key: innovative approaches are needed to tackle the medicine access challenge!
The conference aims to bring together thought leaders from around the globe to discuss 'burning' issues in pricing and reimbursement policies of medicines - both from a global as well as European perspective. Current challenges and opportunities will be discussed, in particular limitations and improvement of current policies and innovative options for the future.
In order to foster the debate on equitable access to affordable and cost-effective medicines, the following perspectives will be discussed at the conference:
Strand 1: Local challenges, global learnings? What can other countries learn from best-practice examples in the field of pricing and reimbursement of medicines?
Strand 2: 'Fake' prices - Are price surveys still useful? The value of list prices against the backdrop of external price referencing and managed entry agreements.
Strand 3: Fix the future? Innovative policy options need to be developed, agreed upon and implemented.
The WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies in Vienna invites you to take part in the discussions with renowned experts and high-level representatives in the pharmaceutical field.
Who should attend the conference:
· Public authorities responsible pricing and reimbursement of medicines (policy makers, administration)
· Payers in the health care system (e.g. social health insurance , ministries, medicines agencies, private health insurance institutions)
· Researchers, academics, students
· Patients and consumers and their associations
· Health professionals (e.g. physicians, pharmacists) and their associations
· Economic actors (e.g. pharmaceutical companies and their associations)
· Editors, journalists
For further information on the Conference please visit the Conference Website:
https://ppri.goeg.at/ppriconference2019
Registration for the Conference: http://events.goeg.at
Call for abstracts:
https://ppri.goeg.at/ppriconference/abstracts (Deadline: 31 May 2019)
Do not hesitate to contact the PPRI Conference Organizing Team: ppriconference@goeg.at<mailto:ppriconference@goeg.at>
Please feel free to share this invitation with your colleagues and with your networks.
Kind regards,
Nina Zimmermann
Vienna WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies
ppriconference@goeg.at
Nina Zimmermann <Nina.Zimmermann@goeg.at>
Mag.(FH) Nina Zimmermann, MA
WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies
Gesundheit Österreich GmbH / Austrian Public Health Institute
Stubenring 6
1010 Wien
T: +43 1 515 61-132
F: +43 1 513 84 72
nina.zimmermann@goeg.at<mailto:romana.landauer@goeg.at>
Skype: nina_zimmermann
www.goeg.at<http://www.goeg.at/>
Diese Nachricht und allfällige angehängte Dokumente sind vertraulich und nur für den/die Adressaten bestimmt. Sollten Sie nicht der beabsichtigte Adressat sein, ist jede Offenlegung, Weiterleitung oder sonstige Verwendung dieser Information nicht gestattet. In diesem Fall bitten wir, den Absender zu verständigen und die Information zu vernichten. Für Übermittlungsfehler oder sonstige Irrtümer bei Übermittlung besteht keine Haftung.
This message and any attached files are confidential and intended solely for the addressee(s). Any publication, transmission or other use of the information by a person or entity other than the intended addressee is prohibited. If you receive this in error please contact the sender and delete the material. The sender does not accept liability for any errors or omissions as a result of the transmission.